BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28422742)

  • 21. Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.
    John J; Woolaver RA; Popolizio V; Chen SMY; Ge H; Krinsky AL; Vashisht M; Kramer Y; Chen Z; Wang JH
    Front Immunol; 2022; 13():992630. PubMed ID: 36330507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral spatial heterogeneity of tumor-infiltrating lymphocytes is a significant factor for precisely stratifying prognostic immune subgroups of microsatellite instability-high colorectal carcinomas.
    Jung M; Lee JA; Yoo SY; Bae JM; Kang GH; Kim JH
    Mod Pathol; 2022 Dec; 35(12):2011-2022. PubMed ID: 35869301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
    Joshi K; de Massy MR; Ismail M; Reading JL; Uddin I; Woolston A; Hatipoglu E; Oakes T; Rosenthal R; Peacock T; Ronel T; Noursadeghi M; Turati V; Furness AJS; Georgiou A; Wong YNS; Ben Aissa A; Sunderland MW; Jamal-Hanjani M; Veeriah S; Birkbak NJ; Wilson GA; Hiley CT; Ghorani E; Guerra-Assunção JA; Herrero J; Enver T; Hadrup SR; Hackshaw A; Peggs KS; McGranahan N; Swanton C; ; Quezada SA; Chain B
    Nat Med; 2019 Oct; 25(10):1549-1559. PubMed ID: 31591606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
    Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
    Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
    Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
    J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma.
    Chen Z; Zhang C; Pan Y; Xu R; Xu C; Chen Z; Lu Z; Ke Y
    J Pathol; 2016 Aug; 239(4):450-8. PubMed ID: 27171315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIL expansion with high dose IL-2 or low dose IL-2 with anti-CD3/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones.
    Kongkaew T; Thaiwong R; Tudsamran S; Sae-Jung T; Sengprasert P; Vasuratna A; Suppipat K; Reantragoon R
    J Immunol Methods; 2022 Apr; 503():113229. PubMed ID: 35101548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High diversity of the T-cell receptor repertoire of tumor-infiltrating lymphocytes in basal cell carcinoma.
    Omland SH; Hamrouni A; Gniadecki R
    Exp Dermatol; 2017 May; 26(5):454-456. PubMed ID: 27714856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
    Reuben A; Gittelman R; Gao J; Zhang J; Yusko EC; Wu CJ; Emerson R; Zhang J; Tipton C; Li J; Quek K; Gopalakrishnan V; Chen R; Vence LM; Cascone T; Vignali M; Fujimoto J; Rodriguez-Canales J; Parra ER; Little LD; Gumbs C; Forget MA; Federico L; Haymaker C; Behrens C; Benzeno S; Bernatchez C; Sepesi B; Gibbons DL; Wargo JA; William WN; Swisher S; Heymach JV; Robins H; Lee JJ; Sharma P; Allison JP; Futreal PA; Wistuba II; Zhang J
    Cancer Discov; 2017 Oct; 7(10):1088-1097. PubMed ID: 28733428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.
    Turcotte S; Gros A; Tran E; Lee CC; Wunderlich JR; Robbins PF; Rosenberg SA
    Clin Cancer Res; 2014 Jan; 20(2):331-43. PubMed ID: 24218514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
    Wei T; Leisegang M; Xia M; Kiyotani K; Li N; Zeng C; Deng C; Jiang J; Harada M; Agrawal N; Li L; Qi H; Nakamura Y; Ren L
    Oncoimmunology; 2021 May; 10(1):1929726. PubMed ID: 34104546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Genomic Complexity Defines Intratumor Heterogeneity and Tumor Aggressiveness in Liver Cancer.
    Kwon SM; Budhu A; Woo HG; Chaisaingmongkol J; Dang H; Forgues M; Harris CC; Zhang G; Auslander N; Ruppin E; Mahidol C; Ruchirawat M; Wang XW
    Sci Rep; 2019 Nov; 9(1):16930. PubMed ID: 31729408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
    Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.
    Shah P; Forget MA; Frank ML; Jiang P; Sakellariou-Thompson D; Federico L; Khairullah R; Neutzler CA; Wistuba I; Chow CB; Long Y; Fujimoto J; Lin SY; Maitra A; Negrao MV; Mitchell KG; Weissferdt A; Vaporciyan AA; Cascone T; Roth JA; Zhang J; Sepesi B; Gibbons DL; Heymach JV; Haymaker CL; McGrail DJ; Reuben A; Bernatchez C
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35110355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memory T-lymphocytes are the main population of tumor-infiltrating lymphocytes obtained from human primary liver tumors.
    Shimizu Y; Watanabe A; Whiteside TL
    J Hepatol; 1992 Sep; 16(1-2):197-202. PubMed ID: 1484153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
    Nishimura MI; Kawakami Y; Charmley P; O'Neil B; Shilyansky J; Yannelli JR; Rosenberg SA; Hood L
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):85-94. PubMed ID: 7804531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
    Braun MW; Abdelhakim H; Li M; Hyter S; Pessetto Z; Koestler DC; Pathak HB; Dunavin N; Godwin AK
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal Expansion of Tumor-Infiltrating T Cells and Analysis of the Tumor Microenvironment within Esophageal Squamous Cell Carcinoma Relapsed after Definitive Chemoradiation Therapy.
    Mori T; Kumagai K; Nasu K; Yoshizawa T; Kuwano K; Hamada Y; Kanazawa H; Suzuki R
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.
    Brohl AS; Sindiri S; Wei JS; Milewski D; Chou HC; Song YK; Wen X; Kumar J; Reardon HV; Mudunuri US; Collins JR; Nagaraj S; Gangalapudi V; Tyagi M; Zhu YJ; Masih KE; Yohe ME; Shern JF; Qi Y; Guha U; Catchpoole D; Orentas RJ; Kuznetsov IB; Llosa NJ; Ligon JA; Turpin BK; Leino DG; Iwata S; Andrulis IL; Wunder JS; Toledo SRC; Meltzer PS; Lau C; Teicher BA; Magnan H; Ladanyi M; Khan J
    Cell Rep; 2021 Nov; 37(8):110047. PubMed ID: 34818552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.